Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the single-dose relative bioavailability of
Ranbaxy and Abbott (TriCor) 160 mg fenofibrate tablets under fed conditions.